Life is complicated: so is apoCIII
Open Access
- 1 August 2019
- journal article
- editorial
- Published by Elsevier in Journal of Lipid Research
- Vol. 60 (8) , 1347-1349
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and HumansCirculation Research, 2013
- Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycansJournal of Clinical Investigation, 2013
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent CardioprotectionScience, 2008
- Endogenous ApoE Expression Modulates Adipocyte Triglyceride Content and TurnoverDiabetes, 2006
- Overexpression ofapoC-III produces lesser hypertriglyceridemia in apoB-48-only gene-targeted micethan in apoB-100-only miceJournal of Lipid Research, 2004
- Apolipoprotein E Effectively Inhibits Lipoprotein Lipase-mediated Lipolysis of Chylomicron-like Triglyceride-rich Lipid Emulsions andJournal of Biological Chemistry, 1996
- Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.Journal of Clinical Investigation, 1992
- Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.Journal of Clinical Investigation, 1986
- Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery DiseaseNew England Journal of Medicine, 1982
- Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoproteinBiochemical and Biophysical Research Communications, 1972